BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36297384)

  • 21. Development of a New Radiofluorinated Quinoline Analog for PET Imaging of Phosphodiesterase 5 (PDE5) in Brain.
    Liu J; Wenzel B; Dukic-Stefanovic S; Teodoro R; Ludwig FA; Deuther-Conrad W; Schröder S; Chezal JM; Moreau E; Brust P; Maisonial-Besset A
    Pharmaceuticals (Basel); 2016 Apr; 9(2):. PubMed ID: 27110797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the binding properties of T-773 as a PET radioligand for phosphodiesterase 10A.
    Harada A; Suzuki K; Miura S; Hasui T; Kamiguchi N; Ishii T; Taniguchi T; Kuroita T; Takano A; Stepanov V; Halldin C; Kimura H
    Nucl Med Biol; 2015 Feb; 42(2):146-54. PubMed ID: 25451212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First-in-Human Assessment of the Novel PDE2A PET Radiotracer 18F-PF-05270430.
    Naganawa M; Waterhouse RN; Nabulsi N; Lin SF; Labaree D; Ropchan J; Tarabar S; DeMartinis N; Ogden A; Banerjee A; Huang Y; Carson RE
    J Nucl Med; 2016 Sep; 57(9):1388-95. PubMed ID: 27103022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbon-11 labeled papaverine as a PET tracer for imaging PDE10A: radiosynthesis, in vitro and in vivo evaluation.
    Tu Z; Xu J; Jones LA; Li S; Mach RH
    Nucl Med Biol; 2010 May; 37(4):509-16. PubMed ID: 20447563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical localization of phosphodiesterase 2A in multiple mammalian species.
    Stephenson DT; Coskran TM; Wilhelms MB; Adamowicz WO; O'Donnell MM; Muravnick KB; Menniti FS; Kleiman RJ; Morton D
    J Histochem Cytochem; 2009 Oct; 57(10):933-49. PubMed ID: 19506089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [18F]JNJ42259152 binding to phosphodiesterase 10A, a key regulator of medium spiny neuron excitability, is altered in the presence of cyclic AMP.
    Ooms M; Attili B; Celen S; Koole M; Verbruggen A; Van Laere K; Bormans G
    J Neurochem; 2016 Dec; 139(5):897-906. PubMed ID: 27664396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
    Slavik R; Müller Herde A; Haider A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
    J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of Novel Analogs of the Monocarboxylate Transporter Ligand FACH and Biological Validation of One Potential Radiotracer for Positron Emission Tomography (PET) Imaging.
    Sadeghzadeh M; Wenzel B; Gündel D; Deuther-Conrad W; Toussaint M; Moldovan RP; Fischer S; Ludwig FA; Teodoro R; Jonnalagadda S; Jonnalagadda SK; Schüürmann G; Mereddy VR; Drewes LR; Brust P
    Molecules; 2020 May; 25(10):. PubMed ID: 32423056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical evaluation of a promising C-11 labeled PET tracer for imaging phosphodiesterase 10A in the brain of living subject.
    Liu H; Jin H; Yue X; Zhang X; Yang H; Li J; Flores H; Su Y; Perlmutter JS; Tu Z
    Neuroimage; 2015 Nov; 121():253-62. PubMed ID: 26216275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular imaging of σ receptors: synthesis and evaluation of the potent σ1 selective radioligand [18F]fluspidine.
    Fischer S; Wiese C; Maestrup EG; Hiller A; Deuther-Conrad W; Scheunemann M; Schepmann D; Steinbach J; Wünsch B; Brust P
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):540-51. PubMed ID: 21072511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of carbon-11 and fluorine-18 labeled tracers for in vivo visualization of PDE10A.
    Ooms M; Celen S; Koole M; Langlois X; Schmidt M; De Angelis M; Andrés JI; Verbruggen A; Van Laere K; Bormans G
    Nucl Med Biol; 2014 Sep; 41(8):695-704. PubMed ID: 25002365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
    Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
    Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Inhibition Modality for Phosphodiesterase 2A.
    Nakashima K; Matsui H
    SLAS Discov; 2020 Jun; 25(5):498-505. PubMed ID: 32343157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization and first human investigation of FIBT, a novel fluorinated Aβ plaque neuroimaging PET radioligand.
    Yousefi BH; Manook A; Grimmer T; Arzberger T; von Reutern B; Henriksen G; Drzezga A; Förster S; Schwaiger M; Wester HJ
    ACS Chem Neurosci; 2015 Mar; 6(3):428-37. PubMed ID: 25482310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters.
    Goodman MM; Kilts CD; Keil R; Shi B; Martarello L; Xing D; Votaw J; Ely TD; Lambert P; Owens MJ; Camp VM; Malveaux E; Hoffman JM
    Nucl Med Biol; 2000 Jan; 27(1):1-12. PubMed ID: 10755640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective phosphodiesterase-2A inhibitor alleviates radicular inflammation and mechanical allodynia in non-compressive lumbar disc herniation rats.
    Wang JN; Zhao XJ; Liu ZH; Zhao XL; Sun T; Fu ZJ
    Eur Spine J; 2017 Jul; 26(7):1961-1968. PubMed ID: 28283839
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Kirjavainen AK; Forsback S; López-Picón FR; Marjamäki P; Takkinen J; Haaparanta-Solin M; Peters D; Solin O
    Nucl Med Biol; 2018 Jan; 56():39-46. PubMed ID: 29172120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo evaluation of [18F]-FDEGPECO as a PET tracer for imaging the metabotropic glutamate receptor subtype 5 (mGluR5).
    Wanger-Baumann CA; Mu L; Honer M; Belli S; Alf MF; Schubiger PA; Krämer SD; Ametamey SM
    Neuroimage; 2011 Jun; 56(3):984-91. PubMed ID: 21406237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical In Vitro and In Vivo Characterization of Synaptic Vesicle 2A-Targeting Compounds Amenable to F-18 Labeling as Potential PET Radioligands for Imaging of Synapse Integrity.
    Patel S; Knight A; Krause S; Teceno T; Tresse C; Li S; Cai Z; Gouasmat A; Carroll VM; Barret O; Gottmukkala V; Zhang W; Xiang X; Morley T; Huang Y; Passchier J
    Mol Imaging Biol; 2020 Aug; 22(4):832-841. PubMed ID: 31728839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.